CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Clinical trial NCT07077083 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07077083
Sponsor: Massachusetts General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC

Start date: 2026-09-16
Primary completion: 2027-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.